Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCraneware Regulatory News (CRW)

Share Price Information for Craneware (CRW)

Share Price is delayed by 15 minutes
Get Live Data
1,440.00    -50.00 (-3.36%)
Bid:
1,434.00
Ask:
1,442.00
Spread: 8.00 (0.558%)
Market Cap: £493.01m
CRW Live PriceLast checked at - London Stock Exchange

Intraday Craneware Share Chart

Trading Statement

10 Jul 2008 07:00

RNS Number : 7381Y
Craneware plc
10 July 2008
 



Craneware plc

("Craneware" or the "Company")

TRADING UPDATE 

10 July 2008 - Craneware plc, (AIM: CRW) a leader in revenue cycle management software solutions for the US healthcare market, is pleased to give an update today on trading during the year to 30 June 2008. 

The Company has performed strongly during the year, exceeding targets set at the time of the IPO in September, culminating in the signing of the two separate agreements with Catholic Healthcare West and Catholic Health East announced within the last month, revenues from which will only be recognised in subsequent years. 

During the year, the management continued to execute on its stated strategy of broadening the Company's customer base signing up 194 new hospitals during the year, resulting in Craneware's software being used in 950 US hospitals up from 801 at the beginning of the year. Renewal rates for multi-year contracts remain above 90%.

In additional to broadening the customer base, the Company also increased customer penetration through the cross-sale of two additional products, Patient Charge Estimator™ and Pharmacy ChargeLink™, which were launched at the end of the 1st half of the year. Over 30% of new hospital wins during the year included at least one of the newly launched products with additional sales made to existing hospital clients ahead of management's expectations. 

The Board is therefore confident of reporting results for the year ended 30 June 2008 in line with expectations. These results will be announced on Tuesday 9 September 2008. 

Keith Neilson, CEO of Craneware, commented, "We are delighted with the strong growth achieved in the year, underlining our position as the leader in revenue cycle management software in the US. We have exceeded our goals as stated at the time of the Company's IPO in September last year, and are confident in our ability to continue to execute upon our strategy in the year ahead." 

For further information, please contact:

Craneware plc

KBC Peel Hunt

ICIS

+44 (0)1506 407 666

+44 (0)20 7418 8900

+44 (0)20 7651 8688

Keith Neilson, CEO

Oliver Scott

Tom Moriarty

Sandy McDougall, CFO

Deon Veldtman

Caroline Evans-Jones

About Craneware

Founded in 1999, Craneware has headquarters in LivingstonScotland, with offices in FloridaArizona and Kansas, employing over 100 staff. Craneware's products, which include the Company's flagship, Chargemaster Toolkit® assist US healthcare providers in reducing billing errors, ensuring the timely and accurate submission of claims and managing compliance risk. More information about Craneware plc and its services can be found on-line at the Company's corporate website, www.craneware.com

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTRLMFTMMTMBPP
Date   Source Headline
5th Jun 20237:00 amRNSTransaction in Own Shares
2nd Jun 20237:00 amRNSTransaction in Own Shares
1st Jun 20237:00 amRNSTransaction in Own Shares
31st May 20237:00 amRNSTransaction in Own Shares
30th May 20237:00 amRNSTransaction in Own Shares
26th May 20237:22 amRNSTransaction in Own Shares
25th May 20237:00 amRNSTransaction in Own Shares
24th May 20237:00 amRNSTransaction in Own Shares
23rd May 20237:00 amRNSTransaction in Own Shares
22nd May 20237:00 amRNSTransaction in Own Shares
19th May 20237:00 amRNSTransaction in Own Shares
18th May 20237:00 amRNSTransaction in Own Shares
17th May 20237:00 amRNSTransaction in Own Shares
16th May 20237:02 amRNSTransaction in Own Shares
12th May 20239:21 amRNSTransaction in Own Shares
11th May 20237:00 amRNSTransaction in Own Shares
5th May 202312:35 pmRNSNotification of Major Holdings
28th Apr 20237:00 amRNSTransaction in Own Shares
27th Apr 20237:00 amRNSTransaction in Own Shares
26th Apr 20237:00 amRNSTransaction in Own Shares
25th Apr 20237:00 amRNSTransaction in Own Shares
24th Apr 20237:00 amRNSTransaction in Own Shares
21st Apr 20237:00 amRNSTransaction in own shares
19th Apr 20237:00 amRNSTransaction in Own Shares
18th Apr 20237:00 amRNSTransaction in Own Shares
17th Apr 20237:00 amRNSTransaction in Own Shares
14th Apr 20237:00 amRNSBlock Listing Announcement
14th Apr 20237:00 amRNSTransaction in Own Shares
13th Apr 20237:18 amRNSTransaction in Own Shares
12th Apr 20237:00 amRNSShare Buyback Programme
24th Mar 202311:02 amRNSDividend Currency Election
14th Mar 20237:00 amRNSDirector Share Purchase
6th Mar 20237:00 amRNSInterim Results
13th Feb 20235:15 pmRNSHolding(s) in Company
1st Feb 20233:25 pmRNSDirector Share Purchase
27th Jan 20237:31 amRNSDirector Share Purchase
19th Jan 20232:05 pmRNSSecond Price Monitoring Extn
19th Jan 20232:00 pmRNSPrice Monitoring Extension
19th Jan 20237:00 amRNSTrading Update and Notice of Results
25th Nov 20222:14 pmRNSDividend Currency Election
25th Nov 20229:16 amRNSHolding(s) in Company
21st Nov 202211:40 amRNSGrant of Long Term Incentive Plan Awards
15th Nov 20222:25 pmRNSResult of AGM
15th Nov 20227:00 amRNSAGM Statement and Board Appointment
4th Nov 20221:33 pmRNSHolding(s) in Company
14th Oct 20225:22 pmRNSPosting of Annual Report and Notice of AGM
14th Oct 20227:00 amRNSBlock listing Interim Review
11th Oct 20224:19 pmRNSHolding(s) in Company
10th Oct 202211:10 amRNSHolding(s) in Company
10th Oct 202211:02 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.